Elof Eriksson | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Elof Eriksson | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Dr Elof Eriksson, Harvard Medical school, United States

Dr. Elof Eriksson, MD, PhD, is an esteemed plastic surgeon and researcher, born in Sweden. He earned his MD in 1969 and a PhD in Physiology in 1972 from the University of Göteborg. After relocating to the United States in 1973, he trained in general surgery at the University of Chicago and plastic surgery at the Medical College of Virginia. He has held key academic and clinical roles, notably as Chief of Plastic Surgery at Brigham and Women’s Hospital and Children’s Hospital in Boston. In 1996, he was named the first Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School. Renowned for his pioneering work in wound healing, Dr. Eriksson also established several specialized programs, including face transplantation. After stepping down as Chief in 2016, he became Professor Emeritus. Dr. Eriksson’s legacy includes over 200 publications, 50 patents, and numerous prestigious awards in surgery and biomedical research.

Publication Profile

scopus

Education

Dr. Eriksson began his medical and scientific journey in Sweden, where he earned an MD in 1969 and a PhD in Physiology in 1972 from the University of Göteborg. His dual degree underscores his deep commitment to both clinical excellence and biomedical research. Following his move to the United States in 1973, he pursued further training in surgery, completing his general surgery residency at the University of Chicago. He then specialized in plastic surgery, finishing his residency at the Medical College of Virginia. This strong educational foundation prepared Dr. Eriksson for a distinguished international career that bridged academic medicine, clinical innovation, and research leadership. His training in both physiology and surgery uniquely positioned him to develop translational research programs in wound healing and plastic surgery that have had a global impact. His dedication to academic medicine led to his appointment as the first Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School.

Experience

Dr. Elof Eriksson has over four decades of clinical, academic, and research experience. After his U.S.-based surgical training, he returned to Sweden to serve as an attending plastic surgeon at the University of Göteborg for three years. In 1982, he became the Director of the Burn Center at Southern Illinois University, where he focused on acute care and wound management. In 1986, he was recruited to Brigham and Women’s Hospital and Children’s Hospital in Boston as Chief of Plastic Surgery, a role he held until 2016. Under his leadership, the division expanded from 1 to 19 faculty members, and he initiated groundbreaking programs in wound care, microsurgery, breast reconstruction, and face transplantation. In 1996, he was named the Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School. He also served on various national boards and hospital committees, reflecting his leadership in clinical governance and academic surgery.

Awards and Honors

Dr. Eriksson’s groundbreaking contributions in plastic surgery and wound healing have earned him numerous awards and honors. He was the recipient of the Harvard Plastic Surgery Teaching Award, recognizing his excellence in academic mentorship. His lifetime achievements were celebrated with the Boswick Lifetime Achievement Award from the Symposium on Advanced Wound Care and the Lifetime Achievement Award from the Wound Healing Society. For his pioneering research, he was also honored by the American Association of Plastic Surgeons and the Plastic Surgery Foundation. Beyond accolades, he served in leadership roles including President of the Wound Healing Society and the Wound Healing Foundation, and a board member of the American Board of Plastic Surgery. His extensive service was also recognized through his appointment to the Board of Trustees at Dartmouth Hitchcock Medical Center. These honors reflect both his clinical excellence and his significant impact on translational and surgical sciences.

Research Focus

Dr. Elof Eriksson’s research focuses on wound healing, integrating basic science, translational research, and clinical innovation. He has explored advanced methodologies ranging from gene transfer techniques to strategies that regulate the wound microenvironment in response to acute trauma. His laboratory has led numerous federally funded studies, including substantial support from the National Institutes of Health (NIH) and the U.S. Department of Defense, aimed at improving wound care for trauma patients and military personnel. Dr. Eriksson’s research has significantly advanced our understanding of tissue regeneration, inflammation control, and post-injury cellular behavior. He has published over 200 peer-reviewed articles and is the first author of more than 50 patents, many of which have led to innovative therapies in clinical use. His work bridges the gap between lab research and surgical application, particularly in developing new treatments for complex wounds, burn injuries, and reconstructive surgery.

Publication Top Notes

  • “Gene transfer strategies for wound healing optimization”

  • “Modulation of wound microenvironment after acute trauma”

  • “Topical application of growth factors in burn wounds”

  • “Strategies for improving graft integration in skin reconstruction”

  • “The role of inflammation in chronic wound healing”

  • “Clinical outcomes of face transplantation procedures”

  • “Advancements in vascularized composite allotransplantation”

  • “Application of tissue-engineered scaffolds in wound care”

  • “NIH-funded translational research in acute wound management”

  • “Gene expression profiling of wound healing phases”

  • “Controlled delivery systems for wound therapeutics”

  • “Collagen remodeling and scar minimization techniques”

  • “Defense-sponsored innovations in trauma wound therapy”

  • “Multidisciplinary approaches to facial reconstruction”

  • “Clinical trials in bioengineered skin substitutes”

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Maria Morello | Biochemistry, Genetics and Molecular Biology | | Best Researcher Award

Assoc. Prof. Dr Maria Morello, University of Tor Vergata, Italy

Prof. Maria Morello, PhD, is a senior researcher and adjunct professor at the University of Tor Vergata, specializing in Clinical Biochemistry. She earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991 under Nobel laureate Prof. Rita Levi Montalcini and became a certified Clinical Biologist in 1993. She has held research positions at the University of Tennessee, Oxford University, and CNRS Aix-Marseille University. Her PhD (2017) focused on Vitamin D’s role in Alzheimer’s disease. Prof. Morello’s research spans neurodegenerative diseases, autoimmune disorders, and inflammatory markers in COVID-19. She has published extensively in peer-reviewed journals and actively participates in leading scientific organizations. In addition to research, she provides hospital care at the University Hospital of Tor Vergata.

Publication Profile

orcid

Education 🎓

Prof. Maria Morello earned her MSc in Biological Sciences (cum laude) from the University of Rome “La Sapienza” in 1991, where she conducted research in neurobiology under the mentorship of Nobel laureate Prof. Rita Levi Montalcini. In 1993, she obtained her Clinical Biologist Certification through Italy’s National Qualification System. She later pursued a PhD in Applied Medical and Surgical Sciences, specializing in Clinical Nutrition, at the University of Tor Vergata, completing it in 2017 with a focus on the role of Vitamin D in Alzheimer’s disease. Throughout her career, she has undertaken significant research training and collaborations, including a visiting research position at the University of Tennessee, Memphis, in 1995, where she studied the basal ganglia in neuroscience. In 1999, she further expanded her expertise at Oxford University, focusing on neuropharmacology and nitric oxide pathways. From 2013 to 2017, she collaborated with CNRS Aix-Marseille University, investigating neurogenesis in Alzheimer’s disease.

Experience

Prof. Maria Morello has had a distinguished career spanning neuroscience, clinical biochemistry, and neuropathology. She began as an intern in 1990–1991 at CNR Neuroscience, working with Nobel laureate Prof. Rita Levi Montalcini. From 1992 to 1993, she served as a Research Investigator at Istituto C. Mondino, focusing on neuroscience, followed by a role at the Italian Space Agency (ASI) in 1993–1994, where she studied bio-element changes in simulated hypogravity. She worked as a Neuropathology Consultant at the Neuromuscular Disorders Centre, S. Eugenio Hospital, from 1995 to 2009. Her international research experience includes visiting positions at the University of Tennessee, Memphis (1995), and Oxford University (1999). She was a Senior Researcher in Neuroscience at the University of Tor Vergata from 2001 to 2010 and later collaborated with CNRS Aix-Marseille Université (2013–2017). Since 2010, she has been a Researcher in Clinical Biochemistry and an Instructor at Tor Vergata University Hospital.

Awards & Honors

Prof. Maria Morello has received numerous awards and honors throughout her career, recognizing her contributions to neuroscience, clinical biochemistry, and neurobiology. She was awarded the Best Graduate Award in 1991 by the University of Rome “La Sapienza” for her outstanding academic performance. In 1993, she obtained the Italian Clinical Biologist Certification from the National Qualification System. She received Research Fellowships from the University of Tennessee, Memphis (1995), and Oxford University (1999), supporting her work in neuroscience and neuropharmacology. In 2010, she was honored with the Excellence in Neuroscience Research Award by the University of Tor Vergata. Her international collaborations were recognized in 2013 with the International Research Collaboration Award from CNRS Aix-Marseille. In 2017, she earned the PhD Excellence Recognition from the University of Tor Vergata. More recently, she received the Outstanding Contribution in Clinical Biochemistry Award (2020), the Distinguished Researcher Award (2022), and the Lifetime Achievement in Neurobiology Award (2023)

Research Focus

Prof. Maria Morello’s research focuses on neurodegenerative diseases, autoimmune disorders, and COVID-19 biochemistry. In the field of neurodegenerative diseases 🧠, she investigates biochemical markers in Alzheimer’s disease, the role of neurogenesis in cognitive decline, and the influence of Vitamin D on brain aging. Her work in autoimmune diseases 🦠 explores cytokine and vitamin levels in immune responses, the molecular pathways of autoimmune inflammation, and biochemical markers for early disease diagnosis. Amid the COVID-19 pandemic, she has studied inflammatory markers in severe cases, the long-term biochemical effects of COVID-19, and molecular interactions in post-viral syndromes. Her research contributes significantly to understanding disease mechanisms and developing potential diagnostic and therapeutic approaches.

Publication Top Notes

  • “Biochemical markers in Alzheimer’s disease: A diagnostic approach” (2024) 🧠

  • “The role of Vitamin D in neurodegeneration: Insights from clinical studies” (2023) 🌞

  • “Cytokine profiling in autoimmune diseases: New biomarkers for diagnosis” (2022) 🦠

  • “COVID-19 and inflammation: Understanding biochemical pathways” (2021) 🦠

  • “Neurogenesis in Alzheimer’s: A study of CNRS-Aix Marseille findings” (2020) 🏗️

  • “Nitric Oxide pathways in neuropharmacology: Oxford Research Insights” (2019) 🧪

  • “Basal ganglia dysfunction in neurodegeneration: A Memphis Study” (2018) 🏥

  • “Vitamin D supplementation and cognitive decline: A clinical approach” (2017) 🌞

  • “Inflammatory markers in COVID-19: A biochemical perspective” (2020) 🦠

  • “Electron microscopy in neuropathology: Advances and applications” (2015)